Aristo Bio-Tech and Lifescience (NSE:ARISTO) ROC %: 0.00% (As of Mar. 2025)


NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
59 GF Score
Price ₹95.70
View Full Analysis

What is Aristo Bio-Tech and Lifescience ROC %?

Aristo Bio-Tech and Lifescience NSE:ARISTO -4.01% 59 ROC % is 0.00% as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 59/100.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Aristo Bio-Tech and Lifescience's annualized return on capital (ROC %) for the quarter that ended in Mar. 2025 was 0.00%.

As of today (2026-06-30), Aristo Bio-Tech and Lifescience's WACC % is 0.00%. Aristo Bio-Tech and Lifescience's ROC % is 0.00% (calculated using TTM income statement data). Aristo Bio-Tech and Lifescience earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Aristo Bio-Tech and Lifescience  (NSE:ARISTO) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Aristo Bio-Tech and Lifescience's WACC % is 0.00%. Aristo Bio-Tech and Lifescience's ROC % is 0.00% (calculated using TTM income statement data). Aristo Bio-Tech and Lifescience earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Aristo Bio-Tech and Lifescience ROC % Related Terms


Aristo Bio-Tech and Lifescience ROC % Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience ROC % Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROC %
Get a 7-Day Free Trial 6.30 8.71 11.51 9.59 8.70

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
ROC % Get a 7-Day Free Trial Premium Member Only 9.93 11.60 7.06 17.55 0.00
NSE:ARISTO
59GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aristo Bio-Tech and Lifescience ROC % Calculation

Aristo Bio-Tech and Lifescience's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2025 is calculated as:

ROC % (A: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2024 ) + Invested Capital (A: Mar. 2025 ))/ count )
=68.631 * ( 1 - 25.68% )/( (567.066 + 605.816)/ 2 )
=51.0065592/586.441
=8.70 %

where

Invested Capital(A: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1272.87 - 699.433 - ( 6.371 - max(0, 835.681 - 1050.506+6.371))
=567.066

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1406.239 - 789.268 - ( 11.155 - max(0, 955.757 - 1157.858+11.155))
=605.816

Aristo Bio-Tech and Lifescience's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2025 is calculated as:

ROC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=-0.016 * ( 1 - 18.48% )/( (606.576 + 605.816)/ 2 )
=-0.0130432/606.196
=-0.00 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2232.833 - 1618.45 - ( 7.807 - max(0, 1762.52 - 1994.53+7.807))
=606.576

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1406.239 - 789.268 - ( 11.155 - max(0, 955.757 - 1157.858+11.155))
=605.816

Note: The Operating Income data used here is two times the semi-annual (Mar. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 0.00% mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a ROC % of 0.00% as of Mar. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's ROC % too high?
Aristo Bio-Tech and Lifescience's current ROC % is 0.00%. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's ROC % compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's ROC % of 0.00% can be compared against companies in the Agriculture industry. The industry median ROC % is 5.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for an Agriculture company?
The median ROC % among Agriculture companies is 5.48, based on 257 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Aristo Bio-Tech and Lifescience and its competitors. For the Agriculture industry, the median ROC % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aristo Bio-Tech and Lifescience's current ROC % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current ROC % of 0.00%. The current ROC % is 0.00%. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current ROC % is 0.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score

Get the complete analysis for NSE:ARISTO

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹95.70
Price